Compounded medications are not FDA-approved. This means they haven’t undergone the same rigorous testing for safety and effectiveness. The FDA advises against using compounded versions unless approved ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

When Tina Jacobson tried to get Ozempic to lose weight, her health insurance provider denied coverage because she was not diabetic. Instead of paying more than $1,000 out of pocket for the Type 2 ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...

Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive retail price tags. But this option will soon close for consumers. The ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. The FDA has issued a warning that people are overdosing ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief ...

Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high demand that the drugmakers have had a hard time keeping up. So compounding pharmacies stepped in to fill the gap, making ...

Following Hims & Hers’ Super Bowl ad for its weight loss product, a debate has emerged over the safety of compounded GLP-1s for patients. Compounded GLP-1s are custom-made by compounding pharmacies ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site. The ad also hit a nerve with the pharma industry, lawmakers and some industry groups. The ad, called "Sick ...